WuXi using Thermo Fisher to equip 28,000L single-use site in China

By Dan Stanton contact

- Last updated on GMT

WuXi using Thermo Fisher to equip 28,000L single-use site in China

Related tags: Thermo fisher, Thermo fisher scientific, Thermo electron

A WuXi Biologics facility tipped to be the world’s largest single-use mammalian cell culture site will be equipped with disposable systems from Thermo Fisher.

Construction on the $150m (€138m) facility in Wuxi City, China, began in 2015​, and the contract manufacturing organisation (CMO) has said it will be the largest mammalian cell culture manufacturing site in the world based on disposable equipment when it opens this year.

And the planned 28,000L of bioreactor capacity is being supplied by Thermo Fisher through fourteen 2,000L single-use systems, Dirk Tillich – VP of Global Sales at Thermo Fisher Scientific owned​ company Finesse Solutions – told delegates at last month’s BPI European Summit in Amsterdam.

As well as the clinical and commercial scale vessels, Thermo Fisher has supplied ten single-use bioreactors as seed vessels at the site, along with glass vessels and perfusion equipment at an on-site plant which opened its doors last year​ as the first phase in the $150m project.

The WuXi plant – located about 100km west of Shanghai – will manufacture a recombinant soluble LAG-3 protein on behalf of Prima Biomed​ among the deals already announced by the CMO.

Related news

Show more

Related products

show more

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Related suppliers

Follow us

Products

View more

Webinars